Quantcast
31.2 C
United States of America
Wednesday, August 4, 2021
- Advertisement -spot_img

TAG

study

High Medicaid Claims Denial Affecting Doc Participation: Study

Medicaid claims are denied at higher rates than are claims with Medicare and commecial insurance plans, and costs for collecting claims are higher with...

Many Norwegians believe the pandemic will be long-lasting, according to new study

According to the Norwegian Corona Monitor survey, almost half of the respondents believe that the corona pandemic in Norway will last for up to...

AZ jab: People may be three times more likely to get Covid symptoms than Pfizer’s – study

The UK is hurtling towards July 19, when England will be released from all remaining coronavirus restrictions. What was expected to be a moment...

Partisan Covid-19 vaccination gap widens, study shows

Pfizer said Thursday it is seeing waning immunity from its coronavirus vaccine and says it is picking up its efforts to develop a booster...

New study finds reason why some people have milder Covid symptoms than others

The vast majority of confirmed COVID-19 cases are considered mild, involving mostly cold-like symptoms to mild pneumonia, according to data. Researchers used blood samples...

Study Compares Isotretinoin Benefits in Different Weight Groups

Although adolescents with acne received different cumulative doses of isotretinoin based on their body mass index, there were no differences in acne clearance, relapse,...

How to live longer: Small daily servings of a red fruit promotes longevity finds new study

Cardiovascular disease (CVD) - a general term for conditions affecting the heart or blood vessels - is the leading cause of morbidity and mortality...

Should I be worried if I am not experiencing side effects from Pfizer Covid jab? New study

Research continues to shed light on the effects of the impact the coronavirus vaccines have on the body. As more arms have become jabbed,...

Pfizer and Moderna Vaccines May Offer Lasting Protection, Study Finds

Here’s what you need to know: The vaccines made by Pfizer-BioNTech and Moderna set off a persistent immune reaction in the body that may protect...

Topical Ruxolitinib Found Safe, Effective in 52-Week AD Study

After treatment with ruxolitinib cream for 52 weeks, between 60% and 80% of atopic dermatitis patients maintained clear or almost clear skin, with no...

Latest news

- Advertisement -spot_img